Information de reference pour ce titreAccession Number: | 00006454-201707000-00004.
|
Author: | Kolasa, Maureen S. RN, MPH *; Tsai, Yuping PhD *; Xu, Jing PhD, MA *; Fenlon, Nancy RN, MS *; Schillie, Sarah MD, MPH, MBA +
|
Institution: | From the (*)Immunization Services Division, National Center for Immunization and Respiratory Diseases; and (+)Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
|
Title: | |
Source: | Pediatric Infectious Disease Journal. 36(7):e175-e180, July 2017.
|
Abstract: | Background: Post-exposure prophylaxis administered to infants shortly after birth prevents approximately 90% of cases of perinatal hepatitis B virus (HBV) transmission. The Advisory Committee on Immunization Practices recommends that all pregnant women be tested for hepatitis B surface antigen (HBsAg) at an early prenatal visit during each pregnancy to detect active infection with HBV. This study sought to determine the proportion and characteristics of pregnant women tested\not tested according to Advisory Committee on Immunization Practices recommendations.
Methods: We analyzed MarketScan databases to assess prenatal HBsAg testing among women with commercial and Medicaid health care coverage according to demographic and clinical characteristics. Pregnant women 15-44 years of age continuously enrolled in a health plan in the MarketScan database during 2013 and 2014 and with a live birth in 2014 were included.
Results: Among commercially insured women, 239,955 (87.7%) received HBsAg testing and 59.6% were tested during their first trimester. Among Medicaid-enrolled women, 57,268 (83.6%) received HBsAg testing and 39.4% were tested during their first trimester. Among women with high risk pregnancies, HBsAg testing occurred in 87.3% of those with commercial insurance and 84.8% with Medicaid. Testing also varied by maternal age; among women with commercial insurance, testing was greatest among women 26-44 years of age, and among women with Medicaid, testing was greatest among younger women (15-25 years). Testing was lowest among women residing in the Northeast (commercial insurance only).
Conclusions: Prenatal HBsAg testing identifies HBV-infected pregnant women so their infants can receive timely immunoprophylaxis. Efforts to optimize HBsAg testing among all pregnant women are needed to further prevent perinatal HBV transmission.
Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
|
Author Keywords: | hepatitis B; immunization; health services; perinatal.
|
References: | 1. Centers for Disease Control and Prevention. Viral Hepatitis Surveillance-United States, 2013. Available at: www.cdc.gov/hepatitis/statistics/index.htm. Accessed January 26, 2016.
2. Smith EA, Jacques-Carroll L, Walker TY, et al. The national Perinatal Hepatitis B Prevention Program, 1994-2008. Pediatrics. 2012;129:609-616.
3. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Morb Mortal Wkly Rep. 2006;55(RR16):1-25.
4. Gentile I, Zappulo E, Buonomo AR, et al. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. Expert Rev Anti Infect Ther. 2014;12:775-782.
5. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, recommendations of the Advisory Committee on Immunization Practices (ACIP) Part I: immunization of infants, children, and adolescents. MMWR Morb Mortal Wkly Rep. 2005; 54(RR16):1-23.
6. Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol. 1994;44:144-151.
7. Kumar M, Singh T, Sinha S. Chronic hepatitis B virus infection and pregnancy. J Clin Exp Hepatol. 2012;2:366-381.
8. Din ES, Wasley A, Jacques-Carroll L, et al. Estimating the number of births to hepatitis B virus-infected women in 22 states, 2006. Pediatr Infect Dis J. 2011;30:575-579.
9. Barbosa C, Smith EA, Hoerger TJ, et al. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program. Pediatrics. 2014;133:243-253.
10. Danielson E. White paper: Health Research Data for the Real World: The MarketScan Databases. 2014. Truven Health Analytics; Available at: http://truvenhealth.com- ouverture dans une nouvelle fenêtre. Accessed July 2, 2014.
11. Truven Health Analytics. MarketScan Research Databases. Available at: http://truvenhealth.com/your-hea...- ouverture dans une nouvelle fenêtre. Accessed February 11, 2016.
12. Dietz PM, Van Handel M, Wang H, et al. HIV testing among outpatients with Medicaid and commercial insurance. PLoS One. 2015;10:e0144965.
13. National Committee of Quality Assurance. Prenatal and Postpartum Care (PPC). Available at: http://www.ncqa.org/portals/0/Pr...- ouverture dans une nouvelle fenêtre. Accessed January 26, 2016.
14. StataCorp. Stata Statistical Software: Release 12. 2011.College Station, TX: StataCorp LP.
15. Kubo A, Shlager L, Marks AR, et al. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med. 2014;160:828-835.
16. Centers for Disease Control and Prevention. Patterns of health insurance coverage around the time of pregnancy among women with live-born infants - Pregnancy Risk Assessment Monitoring System, 29 states, 2009. MMWR Morb Mortal Wkly Rep. 2015;64:1-19.
17. US Department of Health & Human Services. The Affordable Care Act and Maternity Care. Available at: http://www.hhs.gov/healthcare/fa...- ouverture dans une nouvelle fenêtre. Accessed October 26, 2015.
18. US Centers for Medicare & Medicaid Services. Healthcare Coverage If You Are Pregnant or Plan to Get Pregnant. Available at: https://www.healthcare.gov/what-...- ouverture dans une nouvelle fenêtre. Accessed October 26, 2015.
19. Ross CE, Tao G, Patton M, et al. Screening for human immunodeficiency virus and other sexually transmitted diseases among U.S. women with prenatal care. Obstet Gynecol. 2015;125:1211-1216.
20. Leung J, Cannon MJ, Grosse SD, et al. Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data. BMC Infect Dis. 2012;12:334.
21. ICD10Data.com. ICD 10 code book. Available at: http://www.icd10data.com/- ouverture dans une nouvelle fenêtre. Accessed March 10, 2015.
22. Haeri S, Guichard I, Saddlemire S. Maternal characteristics and outcomes associated with late enrollment for care in teenage pregnancies. South Med J. 2009;102:265-268.
23. Chandler D. Late entry into prenatal care in a rural setting. J Midwifery Womens Health. 2002;47:28-34.
24. Ross DS, Rasmussen SA, Cannon MJ, et al. Obstetrician/gynecologists' knowledge, attitudes, and practices regarding prevention of infections in pregnancy. J Womens Health (Larchmt). 2009;18:1187-1193.
25. Schrag SJ, Fiore AE, Gonik B, et al. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol. 2003;101:704-710.
26. Sheikh LA, Sarnquist C, Grieb EM, et al. Prenatal screening for infectious diseases: an analysis of disparities and adherence to policy in California. Matern Child Health J. 2009;13:260-267.
27. Hogben M, St Lawrence JS, Kasprzyk D, et al. Sexually transmitted disease screening by United States obstetricians and gynecologists. Obstet Gynecol. 2002;100:801-807.
28. Epstein B, Grant T, Schiff M, et al. Does rural residence affect access to prenatal care in Oregon? J Rural Health. 2009;25:150-157.
29. Harris DE, Aboueissa AM, Baugh N, et al. Impact of rurality on maternal and infant health indicators and outcomes in Maine. Rural Remote Health. 2015;15:3278.
30. The Statistics Portal. Total Medicaid Enrollment From 1966 to 2015. Available at: http://ww.statistica.com- ouverture dans une nouvelle fenêtre. Accessed June 13, 2016.
31. Schillie S, Walker T, Veselsky S, et al. Outcomes of infants born to women infected with hepatitis B. Pediatrics. 2015;135:e1141-e1147.
|
Language: | English.
|
Document Type: | Original Studies.
|
Journal Subset: | Nursing. Clinical Medicine.
|
ISSN: | 0891-3668
|
NLM Journal Code: | oxj, 8701858
|
DOI Number: | https://dx.doi.org/10.1097/INF.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|